A Bispecific Modeling Framework Enables the Prediction of Efficacy, Toxicity, and Optimal Molecular Design of Bispecific Antibodies Targeting MerTK

被引:0
|
作者
Ran Li
Edward Dere
Mandy Kwong
Mingjian Fei
Rutwij Dave
Shabkhaiz Masih
Joy Wang
Erin McNamara
Haochu Huang
Wei-Ching Liang
Leah Schutt
Amrita V. Kamath
Meric A. Ovacik
机构
[1] Genentech Inc.,Preclinical and Translational Pharmacokinetics and Pharmacodynamics
[2] Genentech Inc.,Safety Assessment
[3] Biochemical and Cellular Pharmacology,Molecular Oncology
[4] Genentech Inc.,Antibody Engineering
[5] Genentech Inc,undefined
[6] Genentech Inc,undefined
来源
关键词
bispecific antibody; MerTK; modeling enabled prediction; pharmacokinetics; therapeutic index;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 31 条
  • [1] A Bispecific Modeling Framework Enables the Prediction of Efficacy, Toxicity, and Optimal Molecular Design of Bispecific Antibodies Targeting MerTK
    Li, Ran
    Dere, Edward
    Kwong, Mandy
    Fei, Mingjian
    Dave, Rutwij
    Masih, Shabkhaiz
    Wang, Joy
    Mcnamara, Erin
    Huang, Haochu
    Liang, Wei-Ching
    Schutt, Leah
    Kamath, Amrita V.
    Ovacik, Meric A.
    AAPS JOURNAL, 2024, 26 (01):
  • [2] Design and selection of optimal ErbB-targeting bispecific antibodies in pancreatic cancer
    Rabia, Emilia
    Garambois, Veronique
    Dhommee, Christine
    Larbouret, Christel
    Lajoie, Laurie
    Buscail, Yoan
    Jimenez-Dominguez, Gabriel
    Choblet-Thery, Sylvie
    Liaudet-Coopman, Emmanuelle
    Cerutti, Martine
    Jarlier, Marta
    Ravel, Patrice
    Gros, Laurent
    Pirot, Nelly
    Thibault, Gilles
    Zhukovsky, Eugene A. A.
    Gerard, Pierre-Emmanuel
    Pelegrin, Andre
    Colinge, Jacques
    Chardes, Thierry
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [3] Organoid cocultures with autologous T cells to assess toxicity and efficacy of bispecific antibodies
    Jahn, Lorenz
    Kempers, Maxime
    Verker, Roel
    van Dooremalen, Wies
    Steinacher, Linda
    Hombrink, Pleun
    Pourfarzad, Farzin
    Vries, Robert G.
    Cabon, Lauriane
    Boj, Sylvia F.
    CANCER RESEARCH, 2023, 83 (07)
  • [4] Design and Characterization of Bispecific and Trispecific Antibodies Targeting SARS-CoV-2
    Wang, Jiayang
    Qian, Qi
    Jiang, Yushan
    Liang, Zuxin
    Peng, Yun
    Zhao, Wei
    Yang, Yang
    Shen, Chenguang
    VACCINES, 2025, 13 (03)
  • [5] Bispecific Antibodies: A Review of Development, Clinical Efficacy and Toxicity in B-Cell Lymphomas
    Salvaris, Ross
    Ong, Jeremy
    Gregory, Gareth P.
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (05):
  • [6] A novel, rapid, sensitive, and reproducible in vivo platform to assess efficacy and toxicity of bispecific antibodies
    Yang, Jiwon
    Jiao, Jing
    Draheim, Kyle
    Cai, Danying
    Brehm, Michael A.
    Shultz, Leonard D.
    Greiner, Dale L.
    Cheng, Mingshan
    Keck, James G.
    CANCER RESEARCH, 2022, 82 (12)
  • [7] Organoid co-cultures with allogenic T cells to assess toxicity and efficacy of bispecific antibodies
    Oyarce, Cesar
    Bruno, Virginia
    Spagnuolo, Lorenzo
    Beaurivage, Claudia
    Aldeguer, Javier Frias
    Pourfarzad, Farzin
    Vries, Robert G.
    Boj, Sylvia F.
    CANCER RESEARCH, 2024, 84 (06)
  • [8] Mechanistic computational modeling of monospecific and bispecific antibodies targeting interleukin-6/8 receptors
    Ray, Christina M. P.
    Yang, Huilin
    Spangler, Jamie B.
    Mac Gabhann, Feilim
    PLOS COMPUTATIONAL BIOLOGY, 2024, 20 (06)
  • [9] BCMA-CD3 bispecific antibodies: A modeling framework to characterize kinetics of bispecific antibody, T cell, cytokines, and serum M-protein
    Udata, Chandrasekhar
    Wei, Dai
    Jiang, Sibo
    Forgie, Alison
    Hooper, Andrea
    Qiao, Wenlian
    Musante, Cynthia
    Yin, Donghua
    CANCER RESEARCH, 2020, 80 (16)
  • [10] Prospective Design of Anti-Transferrin Receptor Bispecific Antibodies for Optimal Delivery into the Human Brain
    Kanodia, J. S.
    Gadkar, K.
    Bumbaca, D.
    Zhang, Y.
    Tong, R. K.
    Luk, W.
    Hoyte, K.
    Lu, Y.
    Wildsmith, K. R.
    Couch, J. A.
    Watts, R. J.
    Dennis, M. S.
    Ernst, J. A.
    Scearce-Levie, K.
    Atwal, J. K.
    Ramanujan, S.
    Joseph, S.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2016, 5 (05): : 283 - 291